Conversely, Zhou et al., Xu et al. and Hiraoka et al. concluded that HLA-G expression was associated with poor clinical outcome of pancreatic carcinoma patients (Table 10) [56,58,59]. This evidence concerns the gene HLA-G and exocrine pancreatic carcinoma.